RYAN HODGES: Open Payments
NPI 1033413240 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 40 payments from 11 companies in 2025. Trend: 2023 $191 · 2024 $655 · 2025 $776
Food & beverage: $776
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $233 |
| Novo Nordisk Inc | 1 | $125 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $124 |
| E.R. Squibb & Sons, L.L.C. | 3 | $75 |
| Corcept Therapeutics | 3 | $50 |
| Lundbeck LLC | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Exact Sciences Corporation | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: VRAYLAR, Ozempic, JOURNAVX, COBENFY, REXULTI, Korlym, CAPLYTA, QULIPTA.
Industry payments across ID — which companies pay providers there.
